Year: 2022

news_6

Amneal Awarded Sub-License to Manufacture and Commercialize Generic Version of Co-Packaged Nirmatrelvir and Ritonavir in 95 Low- and Middle-Income Countries

- One of 35 global companies selected to manufacture and commercialize generic version of COVID-19 treatment BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals,...